Further data on Nano Covax vaccine’s protective efficacy needed Health

Further data on Nano Covax vaccine’s protective efficacy needed

The National Ethics Committee in Biomedical Research under the Ministry of Health has requested additional reports on the protective efficacy of the homegrown candidate COVID-19 vaccine Nano Covax, requiring that they should be submitted before 3pm on December 22 for review.
Vietnam considers granting registration certificate for conditional circulation to Nano Covax Health

Vietnam considers granting registration certificate for conditional circulation to Nano Covax

The National Committee for Ethics in Biomedical Research under the Ministry of Health (MoH) has agreed that the mid-term results from Nano Covax's phase 3 clinical trials will be submitted to the Advisory Council for the Registration of Circulation of Drugs and Medicinal Ingredients for considering the issuance of a registration certificate for the conditional circulation of the vaccine.
Urgent meeting held to evaluate homegrown COVID-19 vaccine Nano Covax Health

Urgent meeting held to evaluate homegrown COVID-19 vaccine Nano Covax

The National Ethics Committee in Biomedical Research under the Ministry of Health on August 7 held an urgent online meeting to review the results of the first phase of clinical trials of Vietnam’s domestically developed COVID-19 vaccine, Nano Covax, and to pass the mid-term assessment of its second phase.
Third-phase clinic trial of Nano Covax to be sped up Sci-Tech

Third-phase clinic trial of Nano Covax to be sped up

The Ministry of Health and the National Council of Ethics in Biomedical Research on June 25 agreed with the Pasteur Institute in Ho Chi Minh City and the Military Medical University to speed up the third-phase clinical trial of the homegrown COVID-19 vaccine Nano Covax on all the 13,000 volunteers.
Home-grown Nano Covax vaccine enters third-phase trial Videos

Home-grown Nano Covax vaccine enters third-phase trial

The third-phase clinical trial of Vietnam’s first home-grown COVID-19 vaccine, Nano Covax, began on June 10. Being developed by the Nanogen Pharmaceutical Biotechnology JSC based on recombinant DNA/protein technology, the vaccine has undergone two trial phases and proved to be effective against the UK and South African variants.